These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6285268)

  • 21. The effect of (+)-tubocurarine on neuromuscular transmission during repetitive stimulation in the rat, mouse, and frog.
    Magleby KL; Pallotta BS; Terrar DA
    J Physiol; 1981 Mar; 312():97-113. PubMed ID: 6267269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenytoin reduces frequency potentiation of synaptic potentials at the frog neuromuscular junction.
    Selzer ME; David G; Yaari Y
    Brain Res; 1984 Jun; 304(1):149-52. PubMed ID: 6744034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of vinblastine in the frog neuromuscular junction during repetitive stimulation.
    Ruzzier F; Di Gregorio F; Aguilera G; Scuka M
    Exp Neurol; 1984 Jun; 84(3):671-80. PubMed ID: 6609836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of botulinum toxin on neuromuscular transmission in the rat.
    Cull-Candy SG; Lundh H; Thesleff S
    J Physiol; 1976 Aug; 260(1):177-203. PubMed ID: 184273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolonged nerve stimulation causes changes in transmitter release at the frog neuromuscular junction.
    Hinz I; Wernig A
    J Physiol; 1988 Jul; 401():557-65. PubMed ID: 2902219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Facilitation and impulse propagation failure at the frog neuromuscular junction.
    Barton SB; Cohen IS
    Pflugers Arch; 1982 Feb; 392(4):327-34. PubMed ID: 6280127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activity increases quantal size at the frog neuromuscular junction.
    Van der Kloot W; Van der Kloot TE
    Experientia; 1985 Jan; 41(1):47-8. PubMed ID: 3871401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Facilitation of transmission at neuromuscular synapses after "collisions" between endplate potentials and muscle action potentials induced by intracellular stimulation].
    Sharovarova GM
    Fiziol Zh SSSR Im I M Sechenova; 1981 Sep; 67(9):1396-8. PubMed ID: 6271601
    [No Abstract]   [Full Text] [Related]  

  • 29. Neuromodulation of activity-dependent synaptic enhancement at crayfish neuromuscular junction.
    Qian SM; Delaney KR
    Brain Res; 1997 Oct; 771(2):259-70. PubMed ID: 9401746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Control of quantal transmitter release at frog's motor nerve terminals. II. Modulation by de- or hyperpolarizing pulses.
    Dudel J
    Pflugers Arch; 1984 Nov; 402(3):235-43. PubMed ID: 6151643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On the role, inactivation and origin of endogenous adenosine at the frog neuromuscular junction.
    Ribeiro JA; Sebastião AM
    J Physiol; 1987 Mar; 384():571-85. PubMed ID: 2821240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Noradrenaline synchronizes evoked quantal release at frog neuromuscular junctions.
    Bukcharaeva EA; Kim KC; Moravec J; Nikolsky EE; Vyskocil F
    J Physiol; 1999 Jun; 517 ( Pt 3)(Pt 3):879-88. PubMed ID: 10358126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of elabutoxins on neuromuscular transmission in frog skeletal muscles.
    Kato E; Kuba K; Koketsu K
    J Pharmacol Exp Ther; 1978 Feb; 204(2):446-53. PubMed ID: 202696
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of ammodytin L on miniature and endplate potentials in neuromuscular junction of frog m. cutaneus pectoris.
    Frangez R; Krizaj I; Gubensek F; Suput D
    Pflugers Arch; 2000; 440(5 Suppl):R101-2. PubMed ID: 11005629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lithium ions and the release of transmitter at the frog neuromuscular junction.
    Crawford AC
    J Physiol; 1975 Mar; 246(1):109-42. PubMed ID: 237119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synaptic depression in frog neuromuscular junction.
    Glavinović MI
    J Neurophysiol; 1987 Jul; 58(1):230-46. PubMed ID: 2441003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of the action of 4-aminopyridine during repetitive stimulation at the neuromuscular junction.
    Molgó J; Lemeignan M; Lechat P
    Eur J Pharmacol; 1979 Jan; 53(3):307-11. PubMed ID: 32061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of 4-aminopyridine on neuromuscular transmission.
    Lundh H
    Brain Res; 1978 Sep; 153(2):307-18. PubMed ID: 210882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of primidone, phenobarbital and phenylethylmalonamide in the stimulated frog neuromuscular junction.
    Talbot PA; Alderdice MT
    J Pharmacol Exp Ther; 1984 Jan; 228(1):121-7. PubMed ID: 6607337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Run-down of neuromuscular transmission during repetitive nerve activity by nicotinic antagonists is not due to desensitization of the postsynaptic receptor.
    Hong SJ; Chang CC
    Br J Pharmacol; 1991 Apr; 102(4):817-22. PubMed ID: 1677297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.